IPOX Indexes start quarter with sharp losses, China-linked exposure leads: Continued uncertainty over trade and rising yields across the global regions pressured the IPOX Indexes during the first week of the new quarter. Losses were broad-based and heavy in China-linked exposure, while YTD relative gains in the IPOX Europe Indexes (IPOE, IXTE, IPND) narrowed. In the U.S., the IPOX 100 U.S. (IPXO) fell, but outperformed the Russell 2000 (RTY) and Nasdaq 100 (NDX). The biggest losses amongst individual IPOX portfolio holdings on the week belonged to a slew of high-beta, relatively unseasoned growth companies which sharply reversed on profit taking, including after quarterly reports, such as online subscription and personal shopping platform operator Stitch Fix (SFIX US: -39.91%) or application software makers SmartSheet (SMAR US: -17.72%) and Coupa Software (COUP US: -12.72%).
IPOX Focus Stock French fries Maker Lamb Weston (LW US): A tale of a successful U.S. Spin-off: We note the fresh all-time high in IPOX holding IL-based USD billion 13.2 Conagra Brands (CAG US: -1.12%) Spin-off Lamb Weston (LW US), America’s leading producer of French fries, following a strong earnings report. After outperforming by a massive 13,122 bps. since its Spin-off date, the company now closes in on the market cap. of its (former) parent.
IPOX expands Index franchise with launch of “FPXE” ETF: IPOX is pleased to note the launch of the ETF tied to the IPOX 100 Europe (IPOE) in partnership with First Trust Portfolios on Nasdaq U.S. The First Trust IPOX® Europe Equity Opportunities ETF (FPXE) provides investors with exposure to the burgeoning European IPO and Spin-off sector, Europe’s best performing equity sector over the past five years with only minor overlap to the existing benchmarks. Please contact [email protected] to receive further information.
|IPOX Price Returns (%)||Last Week||2017||2018 YTD|
|Exposure: Global/International (xUS) (Price)|
|IPOX® Global (IPGL50) (USD)||-3.67||28.59||1.38|
|IPOX® International (IPXI)* (USD)||-4.65||37.80||-5.67|
|Exposure: United States (Price)|
|IPOX® U.S. Composite (IPXC)* (USD)||-2.82||33.64||5.54|
|IPOX® 100 U.S. (IPXO)* (USD)||-2.79||26.04||6.09|
|IPOX® 30 U.S. (IPXT) (USD)||-1.66||26.63||3.67|
|Exposure: Europe/Nordic Region (Price)|
|IPOX® Europe 30 (IXTE) (EUR)||-3.42||19.27||0.93|
|IPOX® Nordic (IPND) (EUR)||-4.56||17.91||-1.83|
|IPOX® 100 Europe (IPOE)* (USD)||-3.94||41.77||-3.35|
|Exposure: Asia-Pacific/China Region (Price)|
|IPOX® Asia-Pacific (IPTA) (USD)||-3.07||23.30||1.83|
|IPOX® China (CNI) (USD)||-7.34||37.67||-11.11|
|IPOX® Japan (IPJP) (JPY)||-2.76||N/A||N/A|
* Basis for ETPs: FPX US, FPX LN, FPXU FP, FPXI US, TCIP110 IT and CME-traded e-mini IPOX® 100 U.S. Index Futures [Symbol: IPOZ8].
IPO Deal-flow Review & Outlook: Amid turbulent markets, U.S. IPOs continue to leave big “money on the table”. Foreign deals lag anew. Busy week for deals ahead. 10 firms debuted last week across accessible global regions, with the average (median) equally-weighted firm adding +24.16% (+19.20%) based on the difference between the final offering price and Friday’s close. U.S. IPOs (UPWK US, GH US, KOD US, ESTC US) closed the first week with massive gains based on final offer, leaving a combined USD million 447.6 “on the table”. Sentiment abroad remained mixed with most focus on the lackluster debut of luxury car maker Aston Martin (AML LN: -10.53%) in London. At least 13 accessible firms are set to go public this week: Top of the list rank the Frankfurt, Germany, listing of Knorr-Bremse (KBX GR), the century-old brake systems manufacturer and second largest listing in Germany YTD, as well as online furniture seller Westwing (WEW GR), Europe’s Wayfair (W US: -9.97%). Focus amongst firms set to list in the U.S. is on planning software company Anaplan (PLAN US) with ex-Tesla Chief of Accounting as its CFO and FMC’s lithium segment spin-off Livent (LTHM US).
|Select IPOs traded (week: 10/01/2018)||Domicile|
|Aston Martin Lagonda Global Ho||Britain|
|Cairo Investment & Real Estate||Egypt|
|Elastic NV||United States|
|Guardant Health Inc||United States|
|Hana Pharm Co Ltd||South Korea|
|Kodiak Sciences Inc||United States|
|Upwork Inc||United States|
|Select IPOs expected (week: 10/08/2018)||Domicile|
|Allogene Therapeutics Inc||United States|
|Anaplan Inc||United States|
|Livent Corp||United States|
|Midea Real Estate Holding Ltd||China|
|Osmotica Pharmaceuticals PLC||United States|
|Westwing Group AG||Germany|
Lime Brokerage LLC is not affiliated with these service providers. Data, information, and material (“content”) is provided for informational and educational purposes only. This content neither is, nor should be construed as an offer, solicitation, or recommendation to buy or sell any securities. Any investment decisions made by the user through the use of such content is solely based on the users independent analysis taking into consideration your financial circumstances, investment objectives, and risk tolerance. Lime Brokerage LLC does not endorse, offer or recommend any of the services nor information provided by any of the above service providers and any service or information used to execute any trading strategies are solely based on the independent analysis of the user.